The intended trial is to be conducted on Jobelyn, our novel product that has shown very promising potentials in addressing Poverty Related Diseases (PRDs) like HIV by optimizing the efficacy of existing therapeutics when used as adjuvant treatment.
The grant which is offered by European and Developing Countries Clinical Trials Partnership (EDCTP) and has its link below requires Consortia comprising a minimum of three different legal entities to apply. Two of the legal entities must be established in two different European Participating States(2) of the EDCTP Association.
http://www.edctp.org/call/improved-treatment-clinical-management-poverty-related-diseases/